Robotic Partial Nephrectomy
Partial nephrectomy removes the kidney tumour while preserving as much healthy kidney tissue as possible. Robotic assistance may be considered for selected patients and tumours.

Dr. Nitin Singhal is a leading onco-surgeon in Ahmedabad, specialising in the treatment and surgical management of kidney cancer and other urological cancers.
With over 15 years of experience in surgical oncology, he is recognised for his expertise in robotic surgery, HIPEC and minimally invasive techniques, with a patient-focused approach to personalised cancer care.
Kidney cancer, also known as renal cancer, begins in the cells of the kidneys – two bean-shaped organs that filter blood, remove waste and regulate blood pressure.
The most common type in adults is Renal Cell Carcinoma (RCC), while less common forms include Transitional Cell Carcinoma, Wilms’ Tumor and Renal Sarcoma.
Kidney cancer often develops silently and may not cause noticeable symptoms in its early stages. It may sometimes be discovered incidentally during imaging tests performed for other medical conditions.
As the disease progresses, symptoms may include blood in the urine, flank pain, abdominal lumps, unexplained weight loss and fatigue. Early detection is important because kidney cancer can be highly treatable when identified at an earlier stage.
Kidney cancer treatment depends on the type, stage, location and extent of the disease. Surgery remains an important treatment option for many localised kidney cancers.
Dr. Nitin Singhal provides personalised treatment planning based on the patient's condition, cancer stage and overall health.
Several factors may increase the risk of developing kidney cancer.
Kidney cancer may not produce obvious symptoms in its early stages. As the disease progresses, some patients may experience:
Accurate diagnosis and staging help determine the most appropriate treatment approach.
Kidney masses may be evaluated using imaging studies to understand their size, location and relationship with surrounding structures.
Treatment planning considers the tumour size, location, stage, kidney function and overall health of the patient.
The stage of kidney cancer helps determine how far the disease has progressed and guides treatment planning.
At this early stage, the tumour is confined to the kidney and is generally smaller in size. Patients may not experience noticeable symptoms and the tumour may sometimes be discovered incidentally during imaging. Treatment may involve partial nephrectomy or radical nephrectomy depending on the individual case.
The tumour is larger but remains restricted to the kidney without evidence of spread to distant organs. Surgery remains an important treatment option and may include radical nephrectomy or selected minimally invasive approaches.
At this stage, the cancer may extend beyond the kidney into nearby lymph nodes, adrenal structures or major blood vessels. Treatment may involve surgery combined with systemic therapy depending on the extent of disease.
Stage IV kidney cancer has spread to distant organs or structures. Treatment may include targeted therapy, immunotherapy, chemotherapy in selected situations and palliative care, depending on the patient's individual condition.
Treatment is selected according to the tumour, cancer stage, kidney function and patient's overall health.
Partial nephrectomy removes the kidney tumour while preserving as much healthy kidney tissue as possible. Robotic assistance may be considered for selected patients and tumours.
Radical nephrectomy involves removal of the affected kidney and may be recommended for selected larger or more complex kidney tumours.
Minimally invasive surgical techniques may allow selected kidney cancer procedures to be performed through smaller incisions compared with conventional open surgery.
Targeted medicines may be considered for selected patients with advanced kidney cancer based on the characteristics and extent of disease.
Immunotherapy may be used for selected patients with advanced kidney cancer to help the body's immune system recognise and fight cancer cells.
Advanced kidney cancer may require coordinated care involving surgeons, medical oncologists, radiologists and other specialists depending on the patient's treatment needs.
Robotic-assisted kidney surgery can provide the surgeon with enhanced visualisation and precise instrument control. It can be especially useful in selected kidney tumour procedures where preserving healthy kidney tissue is important.
For suitable patients, robotic partial nephrectomy can remove the tumour while preserving functioning kidney tissue. The decision to use robotic surgery depends on the tumour characteristics, anatomy and individual surgical requirements.
Dr. Nitin Singhal is an experienced surgical oncologist in Ahmedabad specialising in complex cancer surgery and robotic surgical techniques.
His approach to kidney cancer focuses on accurate assessment, personalised surgical planning and preservation of healthy kidney function whenever clinically appropriate.
Answers to common questions about kidney cancer, diagnosis, robotic surgery and treatment.
Renal Cell Carcinoma (RCC) is the most common type of kidney cancer in adults. Other types include Transitional Cell Carcinoma, Wilms’ Tumor and Renal Sarcoma, although these are less common.
Kidney cancer can be difficult to detect early because it may not cause obvious symptoms. Some kidney tumours are discovered incidentally during ultrasound, CT or MRI scans performed for other medical reasons.
Kidney cancer may not cause symptoms in its early stages. Possible symptoms include blood in the urine, persistent flank pain, abdominal or flank swelling, unexplained weight loss, fatigue and loss of appetite.
Robotic-assisted kidney surgery uses a robotic surgical platform to provide the surgeon with enhanced visualisation and precise instrument control. It may be used for selected procedures such as partial or radical nephrectomy.
Partial nephrectomy is a kidney-preserving operation in which the tumour is removed while as much healthy kidney tissue as possible is preserved. It may be considered for selected kidney tumours.
Radical nephrectomy involves removal of the affected kidney. It may be recommended for selected larger or more complex kidney tumours where partial nephrectomy is not suitable.
In selected patients, partial nephrectomy can remove the tumour while preserving the remaining healthy kidney tissue. Whether this is appropriate depends on tumour size, location, kidney function and other clinical factors.
Advanced kidney cancer may require systemic treatments such as targeted therapy or immunotherapy. Surgery may also have a role in selected cases. Treatment is determined according to the extent of disease and the patient's overall condition.
Not every kidney mass automatically requires immediate surgery. The appropriate management depends on the nature and characteristics of the tumour, patient health, kidney function and other clinical considerations.
You should seek medical evaluation if you notice blood in the urine, persistent flank pain, an abdominal or flank lump, unexplained weight loss or other concerning symptoms. An abnormal kidney mass found on imaging also warrants appropriate specialist evaluation.
If you or a loved one has been diagnosed with kidney cancer or has an abnormal kidney mass, consult an experienced surgical oncologist to understand the available treatment options.
Dr. Nitin Singhal has been recognised for his contribution to cancer care and surgical oncology, reflecting his commitment to advanced surgical techniques, clinical excellence and patient-centred care.
Surgical oncology training from Tata Memorial Hospital, Mumbai.
Expertise across complex and multidisciplinary cancer surgery.
Honoured for excellence in healthcare and surgical oncology.
Focus on evidence-based and personalised cancer treatment.
Recognition that reflects a continued commitment to excellence in cancer care.